Cost-Effectiveness of Rivaroxaban for the Prevention of Stroke in Patients With Non-Valvular Atrial Fibrillation – A Multinational Study
Value in Health - United Kingdom
doi 10.1016/j.jval.2013.03.1481
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2013
Authors
Publisher
Elsevier BV